Sales & Marketing News | pharmaphorum

News

Regeneron recruits Roche to make COVID-19 antibody drug REGN...

Roche has agreed to help Regeneron manufacture its COVID-19 antibody cocktail REGN-COV2, which started late-stage clinical testing a few weeks ago, in a deal that could more th

News

Creative agency woolley pau regains independence after buyou...

Healthcare marketing agency woolley pau has gone back to its independent roots following a management buyout by three of its senior team.

News

Porterhouse Medical Group joins imc group

Porterhouse Medical Group has joined up with imc (integrated medhealth communication) group, a healthcare communications and consulting agency.

News

Roche takes on Alexion as FDA approves satralizumab in NMOSD

The FDA has approved Roche’s satralizumab for the rare autoimmune disorder Neuromyelitis Optica Spectrum Disorder (NMOSD), under the brand name Enspryng.

News

Cello Health acquired for £182m by private equity firm

Cello Health has been acquired by Arsenal Capital Partners, a private equity firm investing in healthcare and industrials companies.

News

The unprecedented challenge of pricing a coronavirus vaccine

EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 va...

The European Commission has placed its first advance order for a coronavirus vaccine, snapping up 300 million doses of AstraZeneca’s ChAdOx1 candidate developed by the Universi

Regeneron recruits Roche to make COVID-19 antibody drug REGN...

Creative agency woolley pau regains independence after buyou...

Porterhouse Medical Group joins imc group

Roche takes on Alexion as FDA approves satralizumab in NMOSD

Cello Health acquired for £182m by private equity firm

EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 va...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks